PALI

Palisade Bio (PALI)

Palisade Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PALI

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	21 : 30	GlobeNewswire Inc.	Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models	NASDAQ:PALI	Palisade Bio Inc
2024/05/20	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PALI	Palisade Bio Inc
2024/05/18	05 : 51	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PALI	Palisade Bio Inc
2024/05/17	05 : 44	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/14	21 : 05	GlobeNewswire Inc.	Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PALI	Palisade Bio Inc
2024/05/14	05 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PALI	Palisade Bio Inc
2024/05/11	05 : 52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PALI	Palisade Bio Inc
2024/05/11	05 : 37	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/11	05 : 37	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/09	07 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/09	07 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/09	06 : 06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PALI	Palisade Bio Inc
2024/05/07	21 : 30	GlobeNewswire Inc.	Palisade Bio Appoints Margery Fischbein to its Board of Directors	NASDAQ:PALI	Palisade Bio Inc
2024/05/07	20 : 30	GlobeNewswire Inc.	Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules	NASDAQ:PALI	Palisade Bio Inc
2024/05/02	21 : 30	GlobeNewswire Inc.	Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules	NASDAQ:PALI	Palisade Bio Inc
2024/05/01	21 : 30	GlobeNewswire Inc.	Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)	NASDAQ:PALI	Palisade Bio Inc
2024/04/23	21 : 30	GlobeNewswire Inc.	Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach	NASDAQ:PALI	Palisade Bio Inc
2024/04/16	21 : 30	GlobeNewswire Inc.	Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool	NASDAQ:PALI	Palisade Bio Inc
2024/04/11	22 : 15	GlobeNewswire Inc.	Palisade Bio to Participate in the Virtual Investor Lunch Break Event	NASDAQ:PALI	Palisade Bio Inc
2024/04/10	21 : 15	GlobeNewswire Inc.	Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™	NASDAQ:PALI	Palisade Bio Inc
2024/04/04	06 : 30	GlobeNewswire Inc.	Palisade Bio Announces 1-for-15 Reverse Stock Split	NASDAQ:PALI	Palisade Bio Inc
2024/03/27	21 : 00	GlobeNewswire Inc.	Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update	NASDAQ:PALI	Palisade Bio Inc
2024/03/07	06 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PALI	Palisade Bio Inc
2024/02/15	22 : 35	GlobeNewswire Inc.	Palisade Bio to Present at Digestive Disease Week (DDW) 2024	NASDAQ:PALI	Palisade Bio Inc
2024/02/15	04 : 54	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PALI	Palisade Bio Inc
2024/02/14	10 : 10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PALI	Palisade Bio Inc
2024/02/14	06 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PALI	Palisade Bio Inc
2024/02/14	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/02/14	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/02/14	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc